US Patent Issued to H. Lundbeck on June 3 for "Catecholamine prodrugs for use in the treatment of Parkinson's diseases" (Danish Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,710, issued on June 3, was assigned to H. Lundbeck A/S (Valby, Denmark).

"Catecholamine prodrugs for use in the treatment of Parkinson's diseases" was invented by Morten Jorgensen (Valby, Denmark), Martin Juhl (Valby, Denmark) and Klaus Gjervig Jensen (Valby, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of formula (Id) that are prodrugs of catecholamine for use in treatment of neurodegenerative diseases and disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating neurodegenerative or neuropsychiatric diseases and disorder...